Vivian Drori

Professor Vivian Drori is a senior neurologist at Ichilov Medical Center in Israel, where she has made significant contributions to the research and treatment of neurodegenerative diseases, particularly Amyotrophic Lateral Sclerosis (ALS). She has been actively involved in a promising Phase 2 clinical trial for a new drug called PrimeC, which shows potential in slowing the progression of ALS, a disease that currently has no effective treatments. Drori emphasizes the importance of innovative therapies for ALS patients and the need for further research to validate these initial findings.